v3.24.0.1
Integration and Restructuring Plans (Tables)
 12 Months Ended
Dec. 31, 2023
Allergan integration plan  
Restructuring charges  
Summary of charges associated with integration plan
The following table summarizes the charges associated with the Allergan acquisition integration plan:
year ended December 31 (in millions)202320222021
Cost of products sold$89 $117 $132 
Research and development7 23 102 
Selling, general and administrative192 399 353 
Total charges $288 $539 $587 
Summary of cash activity in the restructuring reserve
The following table summarizes the cash activity in the recorded liability associated with the integration plan:
year ended December 31 (in millions)
Accrued balance as of December 31, 2020$387 
Charges526 
Payments and other adjustments(658)
Accrued balance as of December 31, 2021255 
Charges377 
Payments and other adjustments(525)
Accrued balance as of December 31, 2022107 
Charges 274 
Payments and other adjustments(338)
Accrued balance as of December 31, 2023$43 
Other restructuring  
Restructuring charges  
Summary of cash activity in the restructuring reserve
The following table summarizes the cash activity in the restructuring reserve for 2023, 2022 and 2021:
(in millions)
Accrued balance as of December 31, 2020$90 
Charges
54 
Payments and other adjustments(111)
Accrued balance as of December 31, 202133 
Charges
193 
Payments and other adjustments(50)
Accrued balance as of December 31, 2022176 
Charges
107 
Payments and other adjustments(87)
Accrued balance as of December 31, 2023$196